Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is -4.82% lower on its value in year-to-date trading and has touched a low of $11.09 and a high of $18.22 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CPRX stock was last observed hovering at around $15.54 in the last trading session, with the day’s gains setting it 0.46%.
Currently trading at $16.00, the stock is 1.46% and 5.04% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing 2.96% at the moment leaves the stock 13.38% off its SMA200. CPRX registered -11.50% loss for a year compared to 6-month gain of 20.75%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.50% loss in the last 1 month and extending the period to 3 months gives it a 9.74%, and is 0.76% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.66% over the week and 3.70% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 167 employees, a market worth around $1.89B and $398.20M in sales. Current P/E ratio is 26.26 and Fwd P/E is 10.29. Profit margin for the company is 17.93%. Distance from 52-week low is 44.27% and -12.18% from its 52-week high. The company has generated returns on investments over the last 12 months (18.26%).
The EPS is expected to grow by 83.33% this year
The shares outstanding are 107.12M, and float is at 101.44M with Short Float at 5.97%.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
The most recent transaction is an insider sale by Tierney David S, the company’s Director. SEC filings show that Tierney David S sold 25,000 shares of the company’s common stock on Apr 08 ’24 at a price of $15.68 per share for a total of $0.39 million. Following the sale, the insider now owns 0.35 million shares.
Catalyst Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 27 ’24 that Elsbernd Brian (Chief Compliance/Legal Officer) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Mar 27 ’24 and was made at $16.44 per share for $0.41 million. Following the transaction, the insider now directly holds 0.12 million shares of the CPRX stock.
Still, SEC filings show that on Dec 15 ’23, Harper Molly (Director) disposed off 14,000 shares at an average price of $14.39 for $0.2 million. The insider now directly holds 0 shares of Catalyst Pharmaceuticals Inc (CPRX).
